Business Standard

Alembic Pharma fully acquires Aleor Dermaceuticals from JV partner

Picks up remaining 40% stake from JV partner Orbicular Pharmaceutical

Alembic Pharmaceuticals ups its US game plan, acquires Orit
Premium

Alembic Pharmaceuticals

Vinay Umarji Ahmedabad
Vadodara-based Alembic Pharmaceuticals Ltd has fully acquired Aleor Dermaceuticals Limited for an undisclosed amount, by picking up the remaining 40 per cent stake from its joint venture (JV) partner Orbicular Pharmaceuticals Technologies Private Limited.

Alembic Pharma, which held 60 per cent stake in Aleor, will now see its skin-related manufacturing and marketing footprint being strengthened with the acquisition even as it complements the former's business across US, and rest of the world. Subject to approval from the National Company Law Tribunal (NCLT) and other regulatory bodies, the Aleor acquisition was approved by Alembic's board of directors.

With dermatology being a high growth

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 29 2022 | 6:26 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com